CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 712 enrolled
Drug / intervention
Ezetimibe +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00730132
NCT00730132N/ACompleted

Observational Study of Approaches to Lipid-lowering Therapy in Russian Patients With Coronary Heart Disease (<<Treat to Goal>>)

Organon and Co·observational·Posted Aug 8, 2008·Updated Feb 9, 2022

In Brief

An observational study evaluating Ezetimibe and Statin for Coronary Heart Disease and Hypercholesterolemia. Completed, enrolled 712 participants.

Detailed Summary

This study is being performed to evaluate what variants of lipid-lowering therapy are used in Russian clinical practice in coronary heart disease (CHD) patients with hypercholesterolemia in whom the initial statin therapy did not achieve low density lipoprotein-cholesterol (LDL-C) goals. Additionally, the efficacy and safety of all variants of modified lipid-lowering therapy are to be evaluated.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 8, 2008
Enrollment StartJan 1, 2008
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 17.9 years ago

Interventions

Ezetimibedrug

Dosage determined by the investigator based on standard and applicable routine clinical practice for CHD and hypercholesterolemia patients

Statindrug

Statin titration for the Statin Dose Titration group, and new statin treatment and dosage for the New Statin group, determined by the investigator based on standard and applicable routine clinical practice for CHD and hypercholesterolemia patients